Purpose. To validate microarray data on cytokeratin 13 (KRT13) and interleukin-1 receptor
antagonist (IL1RN) expression in urothelial carcinoma of the urinary bladder (UCB) and to …

Purpose. To validate microarray data on cytokeratin 13 (KRT13) and interleukin‐1 receptor
antagonist (IL1RN) expression in urothelial carcinoma of the urinary bladder (UCB) and to …

Background: Many researchers have tried to identify bladder cancer biomarkers to reduce
the need for cystoscopy. The aim of this study was to identify and measure appropriate …

Background Urothelial carcinoma (UC) is one of most common genitourinary malignancy
and the spectrum of disease ranges from in situ lesions to muscle-invasive cancers. The non …

Objective: Diagnosis and grading of bladder cancers have a significant impact on treatment
and prognosis. However, there are currently no very sensitive and specific …

Background Cytokines are known to be a key a factor in numerous malignancies and to
exert an important regulatory role in the tumor microenvironment. Interest has grown in …

Background: Bladder cancer is one of the most common cancers worldwide. Expression of
cytokeratin 20 (CK 20) could be used as a biomarker in different epithelia to determine …

Purpose We investigated the relationship between the distribution of the IL-1RN, TNF-β and
IL-4 polymorphism and the clinical features of bladder cancer. Materials and methods A total …

Background Typically, the overexpressed keratin 7 (KRT7) is considered a validated
therapeutic target and prognosis marker in bladder cancer. However, the crucial roles of …

Results We found that IL-1α was highly expressed in BCa patients while highly expressed IL-
1α was significantly related to short overall survival and progression-free survival in BCa as …